TNFAIP3 Interacting Protein 3 Is an Activator of Hippo‐YAP Signaling Protecting Against Hepatic Ischemia/Reperfusion Injury

Junjie Zhou,Manli Hu,Meiling He,Xiaoming Wang,Dating Sun,Yongping Huang,Xu Cheng,Jiajun Fu,Jie Cai,Tengfei Ma,Song Tian,Yufeng Hu,Fengjiao Hu,Dan Liu,Yanqi He,Lanlan Yan,Zhi‐Gang She,Xiao‐Jing Zhang,Yan‐Xiao Ji,Hui Liu,Hongliang Li,Hailong Yang,Peng Zhang
DOI: https://doi.org/10.1002/hep.32015
IF: 17.298
2021-08-30
Hepatology
Abstract:<section class="article-section__content"><h3 class="article-section__sub-title section1"> Background &amp; Aims</h3><p>Hepatic ischemia/reperfusion (I/R) injury, a common clinical problem that occurs during liver surgical procedures, causes a large proportion of early graft failure and organ rejection cases. The identification of key regulators of hepatic I/R injury may provide potential strategies to clinically improve the prognosis of liver surgery. Here, we aimed to identify the role of TNFAIP3 interacting protein 3 (TNIP3) in hepatic I/R injury and to further reveal its immanent mechanisms.</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Methods &amp; Results</h3><p>In the present study, we found that hepatocyte TNIP3 was markedly upregulated in the livers of both individuals and mice subjected to I/R surgery. Hepatocyte-specific <i>Tnip3</i> overexpression effectively attenuated I/R-induced liver necrosis and inflammation but improved cell proliferation in mice, whereas TNIP3 ablation largely aggravated liver injury. This inhibitory effect of TNIP3 on hepatic I/R injury was found to be dependent on significant activation of the Hippo-YAP signaling pathway. Mechanistically, TNIP3 was found to directly interact with LATS2 and promote NEDD4-mediated LATS2 ubiquitination, leading to decreased YAP phosphorylation at S112 and the activated transcription of factors downstream of YAP. Notably, adeno-associated virus delivered TNIP3 expression in the liver substantially blocked I/R injury in mice. </p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Conclusion</h3><p>TNIP3 is a novel regulator of hepatic IR injury that alleviates cell death and inflammation by assisting ubiquitination and degradation of LATS2 and the resultant YAP activation.TNIP3 represents a promising therapeutic target for hepatic I/R injury to improve the prognosis of liver surgery.</p></section>
gastroenterology & hepatology
What problem does this paper attempt to address?